Learn

This is the second educational video in a three-part series on liver disease for Healthcare Professionals. This activity aims to build general practitioner confidence in the management of patients with known non-alcoholic steatohepatitis who are risk of disease progression. There will be a particular focus on recognising the patient with fatty liver who has risk factors for disease progression that are un- or under-managed. The basis for management of fatty liver at risk of progression is repeated assessment at clinical, biochemical, anatomical and lifestyle levels.

After completing this activity, continue to build your knowledge on Liver Disease by watching:

Part 3: Management of patients with advanced liver disease: The role of the general practitioner

Sponsor: This activity is sponsored by Norgine.  

Details

1. Outline the causes of chronic liver disease in Australia, with an emphasis on the increasing burden of non-alcoholic steatohepatitis in the community
2. Identify the medical and lifestyle factors associated with disease progression towards fibrosis
3. Describe the clinical and biochemical markers of progressing liver disease
4. Outline the methods available for assessing fibrosis in general practice, including non-invasive fibrosis scoring and the role of Fibroscan
5. Detail the management of a patient with progressing liver disease including mitigation of underlying causes, management of nutritional deficiency and infection prevention measures.

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.